SCHEMBL1616445

SCHEMBL1616445

Cc1ccc(S(=O)(=O)OCCC(=O)CCC(=O)CCO)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.43
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39
PPARG P37231 1/20 0.39
PSMD10 O75832 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
SIRT5 Q9NXA8 1/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RAB9A P51151 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
GAA P10253 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
PKM P14618 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1681607 0.88 STAT3 (0.43) STAT3ALDH1A1KMT2ACA12CA1
SCHEMBL28931265 0.88 STAT3 (0.43) STAT3ALDH1A1KMT2ACA12CA1
Ethylene Glycol SCHEMBL1936214 0.82 CA1 (0.48) STAT3ALDH1A1KMT2ACA12CA1
SCHEMBL1258986 0.82 STAT3 (0.47) STAT3ALDH1A1KMT2ACA12CA1
SCHEMBL6573297 0.82 STAT3 (0.49) STAT3ALDH1A1KMT2ACA12CA1
SCHEMBL5792946 0.81 L3MBTL1 (0.54) STAT3ALDH1A1KMT2ACA12CA1
SCHEMBL17763488 0.81 STAT3 (0.47) STAT3ALDH1A1KMT2ACA12CA1
SCHEMBL10860607 0.80 STAT3 (0.46) STAT3ALDH1A1KMT2ACA12CA1
Ethylene SCHEMBL11280661 0.79 STAT3 (0.44) STAT3ALDH1A1KMT2ACA12CA1
Ethylene SCHEMBL7519766 0.79 STAT3 (0.44) STAT3ALDH1A1KMT2ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3337475-B1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES UNIV CALIFORNIA (US) 2024-10-02 EP disclosed
US-12064488-B2 Nitroxide containing amyloid binding agents for imaging and therapeutic uses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-08-20 US disclosed
US-20220202962-A1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2022-06-30 US disclosed
US-10881748-B2 Nitroxide containing amyloid binding agents for imaging and therapeutic uses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-01-05 US disclosed
US-20200246492-A1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-08-06 US disclosed
US-10478513-B2 Nitroxide containing amyloid binding agents for imaging and therapeutic uses THE REGENTS OF THE UNIVERSITY OF CALIFONIA (US) 2019-11-19 US disclosed
US-20180221514-A1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2018-08-09 US disclosed
EP-3337475-A1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES The Regents of The University of California (US) 2018-06-27 EP disclosed
WO-2017031239-A1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-02-23 WO disclosed
US-7923584-B2 Synthesis of difunctional oxyethylene-based compounds THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2011-04-12 US disclosed
US-20090187037-A1 SYNTHESIS OF DIFUNCTIONAL OXYETHYLENE-BASED COMPOUNDS THE GOVERNMENT OF THE UNITED STATES, AS RESPRESENTED BY THE SECRETARY OF THE NAVY 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220202962-A1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES APP, APBA1, CRYAB STAT3 4709/4885ALDH1A1 3820/4885KMT2A 4406/4885
US-10881748-B2 Nitroxide containing amyloid binding agents for imaging and therapeutic uses APP, APBA1, CRYAB STAT3 4709/4885ALDH1A1 3820/4885KMT2A 4406/4885
US-10478513-B2 Nitroxide containing amyloid binding agents for imaging and therapeutic uses APP, APBA1, CRYAB STAT3 4709/4885ALDH1A1 3820/4885KMT2A 4406/4885
US-20090187037-A1 SYNTHESIS OF DIFUNCTIONAL OXYETHYLENE-BASED COMPOUNDS RPS24, RPL24, BRIX1 STAT3 2105/4885ALDH1A1 3773/4885KMT2A 1703/4885
US-12064488-B2 Nitroxide containing amyloid binding agents for imaging and therapeutic uses APP, APBA1, CRYAB STAT3 4709/4885ALDH1A1 3820/4885KMT2A 4406/4885
US-20180221514-A1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES APP, APBA1, CRYAB STAT3 4722/4885ALDH1A1 3882/4885KMT2A 4490/4885
US-20200246492-A1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES APP, APBA1, CRYAB STAT3 4709/4885ALDH1A1 3820/4885KMT2A 4406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.